Official UK procurement notice
NP47818 Glatiramer Injection · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought2 lots · detail below
Published requirement descriptionThe Framework Agreement is for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to NHS Scotland.
Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioning Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.
CPV: Medicinal products for the nervous system · Pharmaceutical products
Lots and requirements (2)Procurement structure
2 lots · no lot values publishedLot #1Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.
This Lot is for the supply of 20mg and 40mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.
Lot #2Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service
This Lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and/or the Authority.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 24 Nov 2021, 11:25 GMT
- Last source update
- 8 Jul 2022, 14:09 BST
- FTS notice number
2022/S 000-018779- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02f9a0Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
Publisher note: The estimated value(s) referred to in Section II.I.7 and Section V2.4 covers the six(6) month modification period of the framework agreement. (SC Ref:699178)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast4 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 2 of these contracts carry the same published figure, £500,243, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Glatiramer Acetate Injection excluding a manufacturer commissioning Home Delivery Service
- Signed
- 4 Jul 2022
- Value
- ceiling above
- Status
- active
Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.
- Signed
- 4 Jul 2022
- Value
- ceiling above
- Status
- active
Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.
- Signed
- 22 Nov 2021
- Value
- £235,114
- Status
- active
Glatiramer Acetate Injection excluding a manufacturer commissioned Home Delivery Service
- Signed
- 22 Nov 2021
- Value
- £265,129
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
3 commercial parties on the notice- MylanFramework contractor
- MylanFramework contractor
- Teva UK LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.